An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber

This study has been completed.

Study NCT00537355 Information provided by Dynavax Technologies Corporation

First Received: September 27, 2007 Last Updated: September 8, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2008
Primary Completion Date:	March 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: September 8, 2010